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permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYThe establishment of self-renewing hepatoblast-like cells (HBCs) from human pluripotent stem cells (PSCs) would realize a stable supply
of hepatocyte-like cells for medical applications. However, the functional characterization of human PSC-derived HBCs was not enough.
To purify and expand human PSC-derived HBCs, human PSC-derived HBCs were cultured on dishes coated with various types of human
recombinant laminins (LN). Human PSC-derived HBCs attached to human laminin-111 (LN111)-coated dish via integrin alpha 6 and
beta 1 and were purified and expanded by culturing on the LN111-coated dish, but not by culturing on dishes coated with other laminin
isoforms. By culturing on the LN111-coated dish, human PSC-derivedHBCsweremaintained formore than 3months andhad the ability
to differentiate into both hepatocyte-like cells and cholangiocyte-like cells. These expandable human PSC-derived HBCs would be
manageable tools for drug screening, experimental platforms to elucidatemechanisms of hepatoblasts, and cell sources for hepatic regen-
erative therapy.INTRODUCTION
Human embryonic stem cells (hESCs) and human induced
pluripotent stem cells (hiPSCs) have the ability to self-repli-
cate and to differentiate into all types of body cells
including hepatoblasts and hepatocytes. Although cryo-
preserved primary human hepatocytes are useful in drug
screening and liver cell transplantation, they rapidly lose
their functions (such as drug metabolism capacity) and
hardly proliferate in in vitro culture systems. On the other
hand, human hepatic stem cells from fetal and postnatal
human liver are able to self-replicate and able to differen-
tiate into hepatocytes (Schmelzer et al., 2007; Zhang
et al., 2008). However, the source of human hepatic stem
cells is limited, and these cells are not available commer-
cially. Therefore, the human pluripotent stem cell (hPSC)-
derived hepatoblast-like cells (HBCs), which have potential
to differentiate into the hepatocyte-like cells, would be an
attractive cell source to provide abundant hepatocyte-like
cells for drug screening and liver cell transplantation.
Because expandable and multipotent hepatoblasts or
hepatic stem cells are of value, suitable culture conditions
for the maintenance of hepatoblasts or hepatic stem cells
obtained from fetal or adult mouse liver were developed
(Kamiya et al., 2009; Tanimizu et al., 2004). Soluble factors,
such as hepatocyte growth factor (HGF) and epidermal
growth factor (EGF), are known to support the proliferation322 Stem Cell Reports j Vol. 1 j 322–335 j October 15, 2013 j ª2013 The Aof mouse hepatic stem cells and hepatoblast (Kamiya et al.,
2009; Tanimizu et al., 2004). Extracellular matrix (ECM)
also affects the maintenance of hepatoblasts or hepatic
stem cells. Laminin can maintain the character of mouse
hepatoblasts (Dlk1-positive cells) (Tanimizu et al., 2004).
However, themethodology formaintaining HBCs differen-
tiated from hPSCs has not been well investigated. Zhao
et al. (2009) have reported that hESC-derived hepatoblast-
like cells (sorted N-cadherin-positive cells were used) could
be maintained on STO feeder cells. Although a culture sys-
tem using STO feeder cells for the maintenance of hepato-
blast-like cells might be useful, there are two problems. The
first problem is that N-cadherin is not a specific marker for
human hepatoblasts. N-cadherin is also expressed in hESC-
derived mesendoderm cells and definitive endoderm (DE)
cells (Sumi et al., 2008). The second problem is that residual
undifferentiated cells could be maintained on STO feeder
cells. Therefore, their culture condition cannot rule out
the possibility of the proliferation of residual undifferenti-
ated cells. Because it is known that hPSC-derived cells
have the potential to form teratomas in the host, the pro-
duction of safer hepatocyte-like cells or hepatoblast-like
cells has been required. Therefore, we decided to purify
hPSC-derived HBCs, which can differentiate into mature
hepatocyte-like cells, and then expand these cells.
In this study, we attempt to determine a suitable culture
condition for the extensive expansion of HBCs deriveduthors
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can be maintained and proliferated on human laminin-111
(LN111)-coated dishes. To demonstrate that expandable,
multipotent, and safe (i.e., devoid of residual undifferenti-
ated cells) hPSC-derived HBCs could be maintained under
our culture condition, the hPSC-derived HBCs were used
for hepatic and biliary differentiation, colony assay, and
transplantation into immunodeficient mice.RESULTS
Human PSC-Derived Hepatoblast-like Cells Could
Adhere onto Human LN111 via Integrin a6 and b1
The HBCs were generated from hPSCs (hESCs and hiPSCs)
as described in Figure 1A (details of the characterization of
hPSC-derived HBCs are described in Figure 3). Definitive
endoderm differentiation of hPSCs was promoted by
stage-specific transient transduction of FOXA2 in addition
to the treatment with appropriate soluble factors (such as
Activin A). Overexpression of FOXA2 is not necessary
for establishing the hPSC-derived HBCs, but it is helpful
for efficient generation of the hPSC-derived HBCs. On
day 9, these hESC-derived populations contained two
cell populations with distinct morphology (Figure 1B).
One population resembled human hepatic stem cells
that were isolated from human fetal liver (shown in red)
(Schmelzer et al., 2007), whereas the other population
resembled definitive endoderm cells (shown in green)
(Hay et al., 2008). The population that resembled human
hepatic stem cells was alpha-1-fetoprotein (AFP) positive,
whereas the other population was AFP negative (Figure 1C,
left). On day 9, the percentage of AFP-positive cells was
approximately 80% (Figure 1C, right). To characterize
these two cell populations (hESC-derived HBC and non-
HBC [NHBC] populations), the colonies were manually
isolated by using a pipette, and then the gene expression
analysis was performed. The gene expression levels of AFP,
CD133, EpCAM, CK8, and CK18 in the hESC-derived
HBCs were higher than those in the bulk population con-
taining both hESC-derived HBCs and NHBCs (CD133,
EpCAM, CK8, and CK18 were named as pan-hepatoblast
markers and are known to be strongly expressed in both
human hepatic stem cells and hepatoblasts [Schmelzer
et al., 2007; Zhang et al., 2008]) (Figure 1D). On the other
hand, the gene expressions of AFP, CD133, EpCAM, CK8,
and CK18 in the hESC-derived NHBCs were hardly de-
tected. The gene expression levels of DE, mesendoderm,
and pluripotent markers in the hESC-derived NHBCs
were higher than those in the hESC-derived HBCs, indi-
cating that the hESC-derived NHBCs could remain in a
more undifferentiated state than the hESC-derived HBCs
(Figures S1A–S1C available online). These results suggestStem Cellthat hepatoblast-like cells could be differentiated from
hPSCs.
To purify the hESC-derived HBCs, these cells were plated
onto dishes coated with various laminins. There are 15
different laminin isoforms in human tissues. Although
laminin is known to be useful to sustain mouse hepato-
blasts (Tanimizu et al., 2004), it remains unknown which
human laminin isoform has the potential to purify and
expand the HBCs. To identify a human laminin isoform
that would be useful for purifying hESC-HBCs, the hESC-
HBCs and -NHBCs were plated onto dishes coated with
various types of commercially available human laminins
(Figure 1E). The hESC-derived HBCs could more efficiently
adhere onto the human LN111-coated dish compared with
hESC-derived NHBCs or unseparated populations (con-
taining both HBCs and NBCs). These data suggest that a
hESC-derived HBC population can be purified from the
unseparated populations by culturing on human LN111-
coated dishes. Because integrins are known to be important
molecules for cell adhesion to the ECM including laminins,
we expected that certain types of integrins would allow
selective adhesion of the hESC-derived HBCs to human
LN111-coated dish. The gene expression levels of various
integrins were examined (Figure 1F). Among the integrin
a subunits, the gene expression level of integrin a6 in the
hESC-derived HBCs was significantly higher than that in
the hESC-derived NHBCs. In contrast, among the integrin
b subunits, the gene expression level of integrin b1 was
higher than those of integrin b2 and b3 in all cell popula-
tions. The hESC-derived HBCs, but not NHBCs, expressed
both integrin a6 and b1 (Figure S1D). Almost all adhesion
of the hESC-derived HBCs to a human LN111-coated dish
was inhibited by both function-blocking antibodies to in-
tegrin a6 and b1 (Figure 1G). These results indicated that
the hESC-derived HBCs could attach to a human LN111-
coated dish via integrin a6 and b1.
The hPSC-Derived HBCs Could Be Proliferated and
Maintained on a Human LN111-Coated Dish
To obtain the purified hESC-derived HBC population, the
hESC-derived cells (day 9) were plated onto a human
LN111-coated dish, and then unattached cells were
removed at 15min after plating (Figure 2A). Among various
laminins, only human LN111 could proliferate (Figure 2B)
and purify (Figure 2C) the AFP-positive population in the
presence of HGF and EGF. During culture on the human
LN111-coated dish, the morphology of the hESC-derived
HBCs gradually changed into that of human hepatoblasts
(Figure S1E) (Schmelzer et al., 2007). Therefore, the charac-
teristics of hESC-derived HBCs might be changed by
culturing on a human LN111-coated dish (details of the
characterization of the hESC-derived HBCs are described
in Figure 3). After culturing on a human LN111-coatedReports j Vol. 1 j 322–335 j October 15, 2013 j ª2013 The Authors 323
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Figure 1. The Human ESC-Derived HBCs Selectively Attached to a Human LN111-Coated Dish via Integrin a6 and b1
(A) The procedure for the differentiation of hESCs (H9) into hepatoblast-like cells (HBCs) is presented schematically. Details are described
in the Experimental Procedures.
(B) Phase-contrast micrographs of the hESC-derived HBCs (red) and non-HBCs (NHBCs) (green) are shown.
(C) The hESC-derived cells (day 9) were subjected to immunostaining with anti-AFP (red) antibodies. The percentage of AFP-positive cells
was examined on day 0 or 9 by using FACS analysis. Data represent the mean ± SD from ten independent experiments. Cells on ‘‘day 0’’ and
‘‘day 9’’ were compared using Student’s t test (p < 0.01).
(D) On day 9, the hESC-derived HBCs and NHBCs were manually picked, and the gene expression levels of AFP and pan-hepatoblast markers
(CD133, EpCAM, CK8, and CK18) were measured by real-time RT-PCR. The gene expression levels of AFP and pan-hepatoblast markers in the
hESC-derived cells (day 9; bulk) were taken as 1.0. Data represent the mean ± SD from four independent experiments. The gene expression
levels in the HBCs were significantly different among the three groups (bulk, HBCs, and NHBCs) based on analysis with one-way ANOVA
followed by Bonferroni post hoc tests (p < 0.05).
(legend continued on next page)
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Self-Renewing Human ESC/iPSC-Derived HBCsdish for a week, almost all of the cells were still AFP positive
(Figures 2C and 2D). To characterize the cells cultured on
various types of human laminins for 7 days, the gene
expression levels of AFP and pan-hepatoblast (CD133,
CK8, CK18, and EpCAM) markers were examined on day
16 (Figure 2E). The gene expression levels of AFP and pan-
hepatoblast markers in the hESC-derived HBCs P1 (HBCs
passaged once) did not change as compared with those of
the hESC-derived HBCs (day 9; HBC P0) (the definitions
of HBC P0, P1, P10, and clone in the present study are
shown in Figure S3). The gene expression levels of mature
hepatocyte and cholangiocytemarkers in the hESC-derived
HBC P1 did not change as compared with those of the
hESC-derivedHBCP0 (day9) (Figure S1F). These results sug-
gest that the characteristics of the hESC-derivedHBC P1 are
similar to those of thehESC-derivedHBCP0, although their
morphologies are quite different from each other. Interest-
ingly, the gene expression levels of mature cholangiocyte
markers in the cells cultured on human LN411- or 511-
coated dishes were upregulated as compared with those of
the hESC-derived HBC P0 (day 9) (Figure S1F), suggesting
thathumanLN411 and511might promotebiliary differen-
tiation. Importantly, both hESC-derived HBCs and hiPSC-
derived HBCs could extensively proliferate on a human
LN111-coated dish for more than 15 passages (Figure 2F)
in the presence of HGF and EGF. Doubling times of hESC
(H9)-derived HBCs and hiPSC (Dotcom)-derived HBCs
were approximately 78 and 67 hr, respectively. Almost all
of the populations cultured on a human LN111-coated
dishwere AFP positive (Figure 2G). Taken together, these re-
sults suggested that the hPSC-derived HBCs would prolifer-
ate and be maintained on a human LN111-coated dish.
Characterization of the hESC-Derived HBCs
To characterize the hESC-derived HBCs, the gene expres-
sion profiles in the hESC-derived purified HBCs (HBC P0),
short-term cultured HBCs (HBCs passaged once [HBC
P1]), and long-term cultured HBC (HBCs passaged ten
times [HBC P10]) were examined. The hESC-derived
HBCs were AFP positive (Figure 3A). Although the hESC-(E) The hESC-derived cells (day 9; bulk), HBCs, and NHBCs were plat
attached cells were counted at 60 min after plating. The cell number t
SD from four independent experiments. The number of attached HBC
groups (bulk, HBCs, and NHBCs) based on analysis with one-way ANO
(F) The gene expression levels of the indicated integrins were measure
time RT-PCR. Data represent the mean ± SD from four independent ex
HBCs were significantly different among three groups (bulk, HBCs,
Bonferroni post hoc tests (p < 0.05).
(G) The adhesion of the hESC-derived HBCs to human LN111-, 211-,
integrin antibodies. IgG antibodies were used as a control for uninhi
60 min after plating. The cell number in the control IgG-treated gro
dependent experiments. ‘‘Control IgG’’ and ‘‘anti-integrin a6 or integrin
See also Figure S1 and Tables S2–S5.
Stem Cellderived HBC P0 were negative for ALB, CK7, and CK19,
the hESC-derived HBC P1 and P10 were positive for these
genes (Figure 3A). Both integrin a6 and b1 (receptors of
LN111) were strongly expressed in the hESC-derived HBC
P0, P1, and P10 (Figure 3B). The gene expression levels of
human hepatic stem cell markers (N-CAM and Claudin 3
[Schmelzer et al., 2007]; these are not expressed in human
hepatoblasts) in the hESC-derived HBC P0 were higher
than those of the hESC-derived HBC P1 and P10 (Fig-
ure 3C). However, the gene expression level of CK19 in
the hESC-derived HBC P0 was lower than that of the
hESC-derived HBC P1 and P10. The gene expression levels
of pan-hepatoblast markers in the hESC-derived HBC P0
were similar to those of the hESC-derived HBC P1 and
P10 (Figure 3D). The gene expression levels of human hep-
atoblast markers (ALB, CYP3A7, and I-CAM (Schmelzer
et al., 2007), none of which were expressed in human he-
patic stem cells) in the hESC-derived HBC P1 and P10
were higher than those of the hESC-derived HBC P0 (Fig-
ure 3E). However, the AFP expression level in the hESC-
derived HBC P0 was similar to that of the hESC-derived
HBC P1 and P10. Because the gene expression levels of
mature hepatocyte and cholangiocyte markers in the
hESC-derived HBC P1 and P10 were not increased as
compared with those in the hESC-derived HBC P0 (Fig-
ure 3F), the hESC-derived HBC P1 and P10 were not segre-
gated into either of the hepatic and biliary lineages.We also
examined the gene expression levels of hepatoblast
markers, which have been reported only in mice and not
in humans (Figure 3G). The characteristics of the hPSC-
derived HBCs are summarized in Figure S3. In addition,
hESC-derived HBC P0 and HBC P10 showed normal karyo-
types (Figure S2A). Therefore, the genetic stability of the
HBCs was confirmed throughout the maintenance period.
Taken together, these results suggest that the hESC-derived
HBC P0 resemble human hepatic stem cells and the hESC-
derived HBC P1 and P10 resemble human hepatoblasts,
although some gene expression patterns in the hESC-
derivedHBCs differ from those in humanhepatic stem cells
and human hepatoblasts, respectively.ed onto human LN111-, 211-, 411-, or 511-coated dishes, and the
hat was initially plated was taken as 1.0. Data represent the mean ±
s on LN111-coated dishes were significantly different among three
VA followed by Bonferroni post hoc tests (p < 0.05).
d in the hESC-derived cells (day 9; bulk), HBCs, and NHBCs by real-
periments. The gene expression levels of integrin a3 and a6 in the
and NHBCs) based on analysis with one-way ANOVA followed by
411-, or 511-coated dishes was examined by using the indicated
bited cell adhesion. The number of attached cells was estimated at
up was taken as 1.0. Data represent the mean ± SD from three in-
b1’’ were compared using Student’s t test. *p < 0.05; ***p < 0.001.
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Figure 2. The hESC-Derived HBCs Could Be Proliferated and Maintained on a Human LN111-Coated Dish
(A) The hESC (H9)-derived cells (day 9) were plated onto a human LN111-coated dish. At 15 min after plating, the unattached cells were
removed.
(B) The hESC (H9)-derived cells (day 9) were plated onto a human LN111, 211, 411, or 511-coated dish, and then the cell number were
counted on days 10, 12, 14, and 16. The cell number on day 10 was taken as 1.0. Data represent the mean ± SD from three independent
experiments. ‘‘LN111’’ was significantly different among four groups (LN111, 211, 411, and 511) on day 14 and 16 based on analysis with
one-way ANOVA followed by Bonferroni post hoc tests (p < 0.05).
(legend continued on next page)
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Self-Renewing Human ESC/iPSC-Derived HBCsIn order to examine whether the hESC-derived HBC P0
have the potential to proliferate clonally on various types
of human laminins, single HBCs were plated on separate
wells of a human LN111-coated 96-well plate at a low
density (one cell per one well) (Table S1). Single cells
that attached to the human LN111-coated dish were AFP
positive and HNF4a positive (Figure S2B). At 7 days after
plating, the hESC-derived HBC colonies (albumin [ALB]-
and cytokeratin 7 [CK7] double positive) (a representative
colony is shown in Figure S2C) were efficiently generated
from the hESC-derived HBC P0 on a LN111-coated
dish. Taken together, these results showed that the hESC-
derived HBCs could be generated from both the hESC-
derived HBC P0 population and the single hESC-derived
HBC P0.The hPSC-Derived HBCs Could Differentiate into Both
Hepatic and Biliary Lineages In Vitro
To examine whether the hESC-derived HBCs have the
potential to differentiate into both hepatic and biliary lin-
eages, first, these cells were differentiated into hepatocyte-
like cells as described in Figure 4A. After 2 weeks of hepatic
differentiation, almost all of the cells were polygonal in
shape (Figure 4B) and were CYP3A4, aAT, and ALB positive
(Figure 4C). The gene expression levels of mature hepato-
cyte markers in the HBC P0-, HBC P10-, or HBC clone-
derived hepatocyte-like cells were higher than those in
the cells that had not undergone hepatic differentiation
(Figure 4D), although the gene expression levels of mature
cholangiocyte markers in these cells did not change (Fig-
ure 4E). The ASGR1-positive cells in the HBC P0-, HBC
P10-, and HBC clone-derived population accounted for
approximately 60%, 90%, and 90% of the total, respec-
tively (Figure 4F). The HBC P0-, HBC P10-, or HBC
clone-derived hepatocyte-like cells had the ability to pro-
duce ALB (Figure 4G, left) and urea (Figure 4G, right).
Next, the hESC-derived HBCs were differentiated into
cholangiocyte-like cells as described in Figure 4H. After
2 weeks of biliary differentiation, tubular structures (Fig-(C) The hESC-derived cells (day 9) were plated onto a human LN111, 21
examined by using FACS analysis on day 9 (before passage and after pa
independent experiments.
(D) The hESC-derived cells cultured on a human LN111-coated dish f
antibodies.
(E) The hESC-derived cells (day 9) were plated onto human LN111, 21
pan-hepatoblast markers (CD133, EpCAM, CK8, and, CK18) were measur
hESC-derived HBCs (the LN111-attached cells were collected at 15 m
(F) The HBCs derived from hESCs (H9) or hiPSCs (Dotcom) were cultu
passage. Data represent the mean ± SD from three independent expe
(G) The percentage of AFP-positive cells was examined by using FACS
(HBCs passaged ten times), and P15 (HBCs passaged 15 times). Data
See also Tables S2 and S3.
Stem Cellure 4I) that were CK7 positive (Figure 4J) were observed.
Although the gene expression levels of mature hepatocyte
markers (Figure 4K) in the HBC P0-, HBC P10-, or HBC
clone-derived cholangiocyte-like cells did not change,
the gene expression levels of mature cholangiocyte
markers (Figure 4L) in these cells were higher than those
in the cells that had not undergone differentiation. Similar
results were obtained by using another hESC line (H1) and
hiPSC line (Dotcom) (Figure S4). Moreover, HBC-derived
hepatocyte-like cells exhibited CYP metabolism capacity
(Figure S5A) and a functional urea cycle that could
response to ammonia (Figure S5B) and were considered
to have potential to be applied in the prediction of
drug-induced hepatotoxicity (Figure S5C). Taken together,
these results indicated that the hPSC-derived HBCs have
the ability to differentiate into both hepatic and biliary
lineages in vitro.In Vivo Cell Transplantation Assays of the hPSC-
Derived HBCs
To examine whether the hESC-derived HBCs could be used
for hepatocyte transplantation, these cells were trans-
planted into CCl4-treated immunodeficient mice as shown
in Figure 5A. The hepatocyte functionality of the hESC-
derived HBC P0 or HBC P10 was assessed by measuring
secretedhumanALB levels in the recipientmice (Figure 5B).
Although human ALB was detected in the mice that were
transplanted with the hESC-derived HBC P0 or HBC P10,
it was not detected in the mice that were not transplanted
with these cells. The ALB-positive cells were observed in
mice transplanted with the hESC-derived HBC P0 or HBC
P10 (Figure 5C). Most of the ALB-positive cells in mice
transplanted with the hESC-derived HBC P10 were AFP
negative (Figure 5D), indicating that transplanted hESC-
derived HBCs were differentiated into mature hepatocyte-
like cells (some of them were binuclear [Figure 5E, white
arrows]). These results demonstrated that hESC-derived
HBCs have the potential to be applied for hepatocyte
transplantation.1, 411, or 511-coated dish. The percentage of AFP-positive cells was
ssage [HBC P0]) or day 16. Data represent the mean ± SD from three
or 7 days were subjected to immunostaining with anti-AFP (green)
1, 411, or 511-coated dishes. The gene expression levels of AFP and
ed by real-time RT-PCR on day 16. The gene expression levels in the
in after plating) were taken as 1.0.
red and cell growth was analyzed by obtaining a cell count at each
riments.
analysis on day 9 (before passage), P1 (HBCs passaged once), P10
represent the mean ± SD from seven independent experiments.
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Figure 3. The hESC-Derived HBCs Were Characterized
(A and B) The hESCs (H9) were differentiated according to Figure 1A and then passaged onto a human LN111-coated dish. The attached
cells (hESC-derived HBCs [HBC P0]) were collected at 15 min after plating. The percentage of AFP-positive, ALB-positive, CK7-positive,
CK19-positive (A), and integrin a6- and integrin b1-double positive (B) cells in the hESC-derived HBC P0, HBC P1 (HBCs passaged once),
and HBC P10 (HBCs passaged ten times) populations was estimated by using FACS analysis. Data represent the mean ± SD from seven
independent experiments.
(legend continued on next page)
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Themain purpose of this studywas to establish and charac-
terize expandable HBCs from hPSCs. First, we identified
that human LN111 could support self-renewal and prolifer-
ation of hPSC-derived HBCs in the presence of HGF and
EGF. Second, we showed that the hPSC-derived HBCs
have thepotential to segregate intobothhepatic andbiliary
lineages, and to integrate into themouse liver parenchyma.
We have demonstrated that the hPSC-derived HBCs
could be maintained on a human LN111-coated dish in
an integrin a6- and b1-dependent manner (Figure 1). It is
known that undifferentiated hPSCs could be maintained
on a human LN511-coated dish but not on a human
LN111-coated dish (Rodin et al., 2010). This might suggest
that human LN111 has the potential not only to selectively
maintain HBCs, but also to eliminate residual undifferenti-
ated cells. Our hepatoblast-like cells could efficiently prolif-
erate for more than 3 months on a human LN111-coated
dish (Figure 2). In the human liver development (during
5–10weeks gestation), laminin is observed in both the peri-
sinusoidal space and portal tracts (Couvelard et al., 1998).
The expression of laminin is localized around the peripor-
tal biliary trees during the later stage of liver development
(Couvelard et al., 1998). Hepatic stem cells reside around
the hepatic portal area (Cle´ment et al., 1988). It is also
known that laminin is accumulated around oval cells
although laminin is not expressed around quiescent
mature hepatocytes (Paku et al., 2001). These facts suggest
that laminin plays an important role in the maintenance
and proliferation of hepatoblasts.
The hPSC-derived HBC P10 and clone were positive for
hepatoblast markers (AFP, ALB, CYP3A7, and I-CAM), but
negative for hepatic stemcellmarkers (N-CAMandClaudin
3) (Figure 3) (Schmelzer et al., 2007). Although the hPSC-
derivedHBCswere able to expandonhumanLN111-coated
dish, Schmelzer et al. showed that human hepatoblasts do
not proliferate under a monolayer culture condition, but
human hepatic stem cells could self-replicate for more
than 6 months (Schmelzer et al., 2007). Although further
investigations of the hepatoblast characteristics in the
hPSC-derived HBCs will be needed in the future, the results
in the present study suggest that the characteristics of
hPSC-derived HBCs expanded on human LN111-coated(C–F) The gene expression levels of hepatic stem cell markers (C), p
hepatocyte (CYP3A4, 7A1, 2C9, and TO) or cholangiocyte markers (in
cells, HBC P0, HBC P1, or HBC P10 by real-time RT-PCR.
(G) The gene expression levels of CD13, CK7, DLK1, and PROX1 were m
P1, or HBC P10 by real-time RT-PCR. Data represent the mean ± SD
evaluated by ANOVA followed by Bonferroni post hoc tests to compare
not share the same letter are significantly different from each other
See also Figures S2 and S3 and Tables S2–S4.
Stem Celldishes were similar to those in humanhepatoblasts isolated
from the human liver (Schmelzer et al., 2007; Zhang et al.,
2008).
The hPSC-derived HBCs had the ability to integrate into
the mouse liver parenchyma (Figure 5), in the manner of
human hepatic stem cells or hepatoblasts (Schmelzer
et al., 2007). The human ALB serum levels (approximately
20–70 ng/ml) in mice transplanted with the hESC-derived
HBC P0 or HBC P10 were comparable to those in the previ-
ous paper in which the hESC-derived definitive endoderm
cells, hepatoblasts, and hepatocyte-like cells were trans-
planted into mice (Liu et al., 2011), but were lower than
those of human liver chimeric mice (Tateno et al., 2004).
Human ALB serum levels would increase if more suitable
host mice, such as urokinase plasminogen activator-SCID
mice were used (Tateno et al., 2004).
In this study, we have developed a technology for the
maintenance and proliferation of hPSC-derived HBCs by
using human LN111. To transplant these cells for purposes
of regenerative medicine, a xeno-free culture condition for
hPSC-derived HBCs must be developed in the future. It is
hoped that the hPSC-derived HBCs and their derivatives
will be helpful in various medical applications, such as
drug screening and regenerative medicine.EXPERIMENTAL PROCEDURES
hESC and hiPSC Culture
The hESC lines (H1 [WA01] and H9 [WA09] [WiCell Research Insti-
tute]) and the hiPSC line, Dotcom (JCRB number: JCRB1327)
(Makino et al., 2009; Nagata et al., 2009), were maintained on a
feeder layer of mitomycin-C-treated mouse embryonic fibroblasts
(Millipore) with ReproStem medium (ReproCELL) supplemented
with 5 and 10 ng/ml fibroblast growth factor 2 (FGF2) (Katayama
Kagaku Kogyo), respectively. H1 and H9 were used following the
Guidelines for Derivation and Utilization of Human Embryonic
Stem Cells of the Ministry of Education, Culture, Sports, Science
and Technology of Japan, and, furthermore, the study was
approved by an independent ethics committee.
In Vitro Hepatoblast Differentiation
The differentiation protocol for the induction of definitive endo-
derm cells and hepatoblasts was based on our previous report with
some modifications (Inamura et al., 2011; Takayama et al., 2012a,
2012b, 2013). In mesendoderm differentiation, hESCs/iPSCs werean-hepatoblast markers (D), hepatoblast markers (E), and mature
tegrin b4 and SOX9) (F) were measured in the definitive endoderm
easured in the hESC-derived definitive endoderm cells, HBC P0, HBC
from three independent experiments. Statistical significance was
four groups (DE cells, HBC P0, HBC P1, and HBC P10). Groups that do
(p < 0.05). DE, definitive endoderm cells.
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Figure 4. The hESC-Derived HBCs Could Differentiate into Both Hepatic and Biliary Lineages
(A) The procedure for differentiation of the hESC (H9)-derived HBC P0, HBC P10, or HBC clone into the hepatocyte-like cells is presented
schematically. Details are described in Experimental Procedures.
(B) Phase-contrast micrographs of the HBC P10-derived hepatocyte-like cells are shown.
(C) The HBC P10-derived hepatocyte-like cells were subjected to immunostaining with anti-CYP3A4 (green), anti-aAT (red), and anti-ALB
(red) antibodies.
(D and E) The gene expression levels of hepatocyte (D) or cholangiocyte (E) markers in HBC P0-, HBC P10-, or HBC clone-derived
hepatocyte-like cells were measured by real-time RT-PCR after 14 days of hepatocyte differentiation. In (D), the gene expression levels in
(legend continued on next page)
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Self-Renewing Human ESC/iPSC-Derived HBCscultured for 2 days on Matrigel (BD Biosciences) in differentiation
hESF-DIFmediumthat contains100ng/mlActivinA(R&DSystems)
(hESF-DIF mediumwas purchased from Cell Science & Technology
Institute; differentiationhESF-DIFmediumwas supplementedwith
10 mg/ml human recombinant insulin, 5 mg/ml human apotransfer-
rin, 10mM2-mercaptoethanol, 10mMethanolamine, 10mMsodium
selenite, and 0.5 mg/ml bovine fatty acid free serum albumin
[all from Sigma]). To generate definitive endoderm cells, the mes-
endoderm cells (day 2) were transduced with 3,000 vector particle
(VP)/cell of FOXA2-expressing adenovirus vectors (Ad-FOXA2) for
1.5 hr and cultured until day 6 on Matrigel in differentiation
hESF-DIF medium supplemented with 100 ng/ml Activin A. For
induction of hepatoblasts, the definitive endoderm cells were
cultured for 3 days on a Matrigel in differentiation hESF-DIF me-
dium supplemented with 30 ng/ml bone morphogenetic protein
4 (BMP4) (R&D Systems) and 20 ng/ml FGF4 (R&D Systems).Establishment and Maintenance of the hPSC-Derived
HBCs
The hPSC-derived HBCs were first purified from the hPSC-derived
cells (day 9) by selecting attached cells on a human recombinant
LN111 (BioLamina)-coated dish at 15 min after plating. The
hPSC-derived HBCs were cultured on a human LN111-coated
dish (2.0 3 104 cells/cm2) in maintenance DMEM/F12 medium
(DMEM/F12 medium [Invitrogen] was supplemented with 10%
FBS, 1 3 insulin/transferrin/selenium, 10 mM nicotinamide, 107
Mdexamethasone (DEX) (Sigma), 20mMHEPES, 25mMNaHCO3,
2 mM L-glutamine, penicillin/streptomycin, 40 ng/ml hepatocyte
growth factor [HGF] [R&D Systems] and 20 ng/ml epidermal
growth factors [EGF] [R&D Systems]). The medium was refreshed
every day. The hPSC-derived HBCs were dissociated with Accutase
(Millipore) into single cells and subcultured every 6 or 7 days.Establishment and Maintenance of a Single hPSC-
Derived HBC
For single-cell culture, the single HBCwas plated to separate well of
human LN111-coated 96-well plate in maintenance DMEM/F12PH 48 hr were taken as 1.0. In (E), the gene expression levels in HBC
mean ± SD from three independent experiments. Student’s t test indic
were significantly higher than those in ‘‘before’’ (p < 0.01).
(F) The efficiency of hepatocyte differentiation was measured by esti
(G) The amounts of ALB (left) and urea (right) secretion were examin
ments. Student’s t test indicated that the percentage of ASGR1-posit
were significantly higher than those in ‘‘before’’ (p < 0.01).
(H) The procedure for the differentiation of the hESC-derived HBC P0
schematically. Details are described in Experimental Procedures.
(I) Phase-contrast micrographs of the HBC P10-derived cholangiocyt
(J) The HBC P10-derived cholangiocyte-like cells were subjected to i
(K and L) The gene expression levels of hepatocyte (K) or cholangio
cholangiocyte-like cells were measured by real-time RT-PCR after 14
levels in PH 48 hr were taken as 1.0. In (L), the gene expression levels i
Data represent the mean ± SD from three independent experiments.
angiocyte markers in ‘‘after’’ were significantly higher than those in ‘‘b
cholangiocyte differentiation; ‘‘After’’ indicates the HBCs after hepato
See also Figures S4 and S5 and Tables S1–S4.
Stem Cellmedium supplemented with 25 mM Y-27632 (ROCK inhibitor)
(Millipore), and then colonies derived from a single cell were
manually picked up and cultured as well as HBCs (these cells
were designated the HBC clone).In Vitro Hepatocyte and Cholangiocyte
Differentiation
To induce hepatocyte differentiation, the hPSC-derived HBC P0,
HBC P10, and HBC clone were cultured for 14 days on a Matri-
gel-coated dish (7.5 3 104 cells/cm2) in HCM (Lonza) supple-
mented with 20 ng/ml HGF, 20 ng/ml Oncostatin M (OsM)
(R&D Systems), and 106 M DEX. To induce cholangiocyte differ-
entiation, the hPSC-derived HBC P0, HBC P10, and HBC clone
were cultured in collagen gel for 14 days. To establish collagen
gel plates, 500 ml collagen gel solution (consisting of 400 ml type
I-A Collagen (Nitta gelatin), 50 ml 10 3 DMEM, and 50 ml of
200 mM HEPES buffer containing 2.2% NaHCO3 and 0.05 M
NaOH) was added to each well, and then the plates were incubated
at 37C for 30 min. The hPSC-derived HBC P0, HBC P10, and HBC
clone (5 3 104 cells) were resuspended in 500 ml differentiation
DMEM/F12medium (differentiationDMEM/F12mediumwas sup-
plemented with 20 mM HEPES, 2 mM L-glutamine, 100 ng/ml
EGF, and 40 ng/ml insulin-like growth factor 2 [ILGF2]), and
then mixed with 500 ml of the collagen gel solution and plated
onto the basal layer of collagen. After 30 min, 2 ml of differentia-
tion DMEM/F12 medium was added to the well.Ad Vectors
Ad vectors were constructed by an improved in vitro ligation
method. The human EF-1a promoter-driven FOXA2-expressing
Ad vectors (Ad-FOXA2) were constructed previously (Takayama
et al., 2012b). All of Ad vectors contain a stretch of lysine residue
(K7) peptides in the C-terminal region of the fiber knob for more
efficient transduction of hESCs, hiPSCs, mesendoderm cells, and
definitive endoderm cells, in which transfection efficiency was
almost 100%, and purified as described previously (InamuraP10 (before differentiation) were taken as 1.0. Data represent the
ated that gene expression levels of the hepatocyte markers in ‘‘after’’
mating the percentage of ASGR1-positive cells using FACS analysis.
ed. Data represent the mean ± SD from three independent experi-
ive cells, the ALB secretion level, and urea secretion level in ‘‘after’’
, HBC P10, or HBC clone into cholangiocyte-like cells is presented
e-like cells are shown.
mmunostaining with anti-CK7 (red) antibodies.
cyte (L) markers in the HBC P0-, HBC P10-, or HBC clone-derived
days of cholangiocyte differentiation. In (K), the gene expression
n HBC P10 (before cholangiocyte differentiation) were taken as 1.0.
Student’s t test indicated that the gene expression levels of chol-
efore’’ (p < 0.01). ‘‘Before’’ indicates the HBCs before hepatocyte or
cyte or cholangiocyte differentiation.
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Figure 5. The hESC-Derived HBCs Were Integrated into the Mouse Liver Parenchyma
(A) The procedure for transplantation of the hESC (H9)-derived HBC P0 and HBC P10 into CCl4 (4 ml/kg)-treated Rag2/IL2 receptor gamma
double-knockout mice is presented schematically.
(B) The human ALB level in recipient mouse serum was measured at 2 weeks after transplantation. Data represent the mean ± SD from six to
eight mice in each group. Statistical significance was evaluated by ANOVA followed by Bonferroni post hoc tests to compare all groups.
Groups that do not share the same letter are significantly different from each other (p < 0.05).
(C) Expressions of the ALB (green) in the liver of transplanted mice were examined by immunohistochemistry at 2 weeks after trans-
plantation.
(D and E) The expressions of AFP (red), ALB (green) (D), and aAT (red) (E) were examined by immunohistochemistry at 2 weeks after hESC-
derived HBC P10 transplantation. White arrows show transplanted cells, which have double nuclei.
See also Tables S2 and S3.
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was determined by using a spectrophotometric method.
Flow Cytometry
Single-cell suspensions of the hPSC-derived cells were fixed with
4% paraformaldehyde (PFA) at 4C for 10 min and then incubated
with the primary antibody (described in Table S2), followed by the
secondary antibody (described in Table S3). Control cells were
incubated with anti-mouse, goat, or rabbit immunoglobulin (Ig)
G antibodies (Santa Cruz Biotechnology) and then incubated
with the secondary antibody. Flow cytometry analysis was per-
formed using a fluorescence-activated cell sorting (FACS) LSR For-
tessa flow cytometer (BD Biosciences). Cell sorting was performed
using a FACS Aria (BD Biosciences).
RNA Isolation and RT-PCR
Total RNA was isolated from hPSCs and their derivatives using
ISOGENE (Nippon Gene). cDNA was synthesized using 500 ng of
total RNAwith a Superscript VILO cDNA synthesis kit (Invitrogen).
Real-time RT-PCRwas performed with SYBR green PCRMaster Mix
(Applied Biosystems) using an Applied Biosystems StemOnePlus
real-time PCR systems. Relative quantification was performed
against a standard curve, and the values were normalized against
the input determined for the housekeeping gene, glyceraldehyde
3-phosphate dehydrogenase. The primer sequences used in this
study are described in Table S4. In addition, we confirmed that
every beta integrin primer used in this manuscript showed a
similar amplification efficacy (Table S5). The amplification
efficiency was calculated from the slope of the standard curve
according to the following formula: e = 10^(1/slope)-1. Every
beta integrin primer used in this manuscript showed a similar
amplification efficacy.
Immunohistochemistry
The cells were fixedwith 4% PFA for 15min and then blockedwith
PBS containing 2% FBS, 2% bovine serum albumin (BSA), and
0.1% Triton X-100 (Wako Pure Chemicals Industries) for 1 hr.
The cells were incubatedwith primary antibody (described in Table
S2) at 4C for overnight, followed by incubation with a secondary
antibody (described in Table S3) at room temperature for 1 hr.
Nuclei were counterstained with DAPI (blue).
ELISA
The hPSC-derivedHBC P0, HBC P10, andHBC clonewere differen-
tiated into the hepatocyte-like cells as described in Figure 4A. The
culture supernatants, which were incubated for 24 hr after fresh
medium was added, were collected and analyzed for the amount
of ALB secretion by ELISA. ELISA kits for ALB were purchased
from Bethyl Laboratories. The amount of ALB secretion was calcu-
lated according to each standard followed by normalization to the
protein content per well. The human ALB amount in mice serum
was also examined by ELISA.
Transplantation of the hESC-Derived HBCs
The hESC-derived HBCs were dissociated using accutase and then
suspendedwithmaintenanceDMEM/F12mediumwithout serum.Stem CellEight- to 10-week-old Rag2/IL2Rg double-knockout mice were
prepared. The hESC-derivedHBCs (13 106 cells) were transplanted
24 hr after administration of CCl4 (4ml/kg) by intrasplenical injec-
tion. Recipient mouse liver and blood were harvested at 2 weeks
after transplantation. The livers were fixed with 4% PFA and pro-
cessed for immunohistochemistry. Human hepatocytes producing
the ALB, AFP, and aAT protein were identified in mouse liver by an
antibody specifically recognizing human but not mouse albumin.
In addition, serum was extracted and subjected to ELISA analysis.
All animal experiments were conducted in accordance with insti-
tutional guidelines.
Urea Secretion
The hPSC-derivedHBCP0, HBC P10, andHBC clonewere differen-
tiated into hepatocyte-like cells as described in Figure 4A. The
culture supernatants, which were incubated for 24 hr after fresh
medium was added, were collected and analyzed for the amount
of urea secretion. The urea measurement kits were purchased
from BioAssay Systems. The amount of urea secretion was calcu-
lated according to each standard followed by normalization to
the protein content per well. In Figure S5B, both the HBC-derived
hepatocyte-like cells and primary human hepatocytes (PHs) (three
lots of cryopreserved human hepatocytes were used), that were
cultured for 48 hr after the cells were plated (PH 48 hr), were
cultured in HCM (containing glutamine) or DMEM (not contain-
ing glutamine; Wako) in the presence or absence of 1 mM ammo-
nium chloride (NH4Cl, Wako) for 24 hr, and then the amount of
urea secretion was measured.
Primary Human Hepatocytes
Three lots of cryopreserved human hepatocytes (lot Hu8072
[CellzDirect], HC2-14, and HC10-101 [Xenotech]) were used. The
vials of hepatocytes were rapidly thawed in a shaking water bath
at 37C; the contents of the vial were emptied into prewarmedCry-
opreserved Hepatocyte Recovery Medium (Gibco) and the suspen-
sion was centrifuged at 100 g for 10 min at room temperature. The
hepatocytes were seeded at 1.25 3 105 cells/cm2 in HCM (Lonza)
containing 10% fetal calf serum (FCS) (Gibco) onto type I
collagen-coated 12-well plates. The medium was replaced with
hepatocyte culturemediumcontaining 10%FCS 6hr after seeding.
The hepatocytes, which were cultured 48 hr after plating the cells,
were used in the experiments.
Adhesion-Blocking Assay Using Integrin Antibody
Twelve-well plates were coated with human recombinant LN111,
211, 411, or 511 (all from BioLamina) and blocked by 1% heat-de-
natured BSA containing PBS. The hESC-derived single cells were
incubated with function-blocking antibodies to integrin a6 and
b1 (at the concentrations as recommended by the manufacturer)
for 30 min, plated on a human LN111-coated 12-well dish, and
allowed to adhere for 1 hr at 37C. After unattached cells were
removed, the remaining adherent cells were fixed for 20 min
with 5% glutaraldehyde. The hESC-derived cells that had adhered
to the wells were stained with 200 ml of 0.3% crystal violet (Wako)
solution at room temperature for 15 min. Excess crystal violet
was then removed, and the wells were washed three times. Fixed
crystal violet was solubilized in 200 ml of 100% ethanol at roomReports j Vol. 1 j 322–335 j October 15, 2013 j ª2013 The Authors 333
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the absorbance at 595 nm of each well using a microtiter plate
reader (Sunrise, Tecan).CYP Activity
Tomeasure the CYP1A2, 2C9, and 3A4 activity of the cells, we per-
formed lytic assays by using P450-GloTM CYP1A2, 2C9, and 3A4
Assay Kits (Promega), respectively. We measured the fluorescence
activity with a luminometer (Lumat LB 9507; Berthold) according
to the manufacturer’s instructions. The CYP activity was normal-
ized with the protein content per well.Karyotyping
This experiment was carried out at Chromosome Science Labo.Cell Viability Tests
Cell viability was assessed by using a WST-8 assay kit (Dojindo),
and the results are presented in Figure S5C. After treatment with
test compounds, such as acetaminophen (Wako) and troglitazone
(Wako) for 24 hr, the cell viability was measured. The control cells
were incubated in the absence of test compounds and were consid-
ered to have 100% viability value. Controls were treated with
DMSO (final concentration 0.1%).
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and five tables and
can be found with this article online at http://dx.doi.org/10.1016/
j.stemcr.2013.08.006.
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